Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
July 31st, 2023
Future or Fad: Will Headless Brands Rewrite the Book on Branding?
Blockchain Technology Group Co-Chair Jeremy S. Goldman, is quoted in the article, “Future or Fad: Will Headless Brands Rewrite the Book on Branding?” published by Culture3. The article discusses the rising popularity of “headless brands” in the blockchain community and the value proposition created from shared ownership of IP. Jeremy is quoted saying, “NFT IP assets can inspire waves of creativity ‘to create new, expressive works’ which are nonetheless tied more obviously to the original IP.” He adds that with comic books, where at the conferences “in between the juggernauts of official franchises are aisles and aisles of fan fiction, none of which is licensed, but they are embraced because they drive ticket sales for the real collections.”
In conclusion, Jeremy notes that by making it possible to license unofficial upstarts with official licensors at scale, NFTs can grow a brand’s entire pie, as well as making it easy for revenue from that fan fiction to be shared with the original franchise.
Read the full article here.
Other Quoted
‘I have been hunted down by HR reps, lawyers, and comms people:’ Developers discuss the pain and prevalence of side work clauses
Wendy Stryker was quoted in a Game Developer article discussing "side work clauses," also known as "moonlighting clauses," in video game industry employment contracts. Read more.
July 30 2026
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
What Cannes Lions Can Teach Us About Advertising’s Most Important Customer
Cannes Lions brought important conversations to the stage about advertising’s most important stakeholder: the public. Read more.
July 2 2026
